BACK

Allen Lefkowitz

Partner

New York Office  |  allen.lefkowitz@torreya.com   |   212.257.5823

Allen Lefkowitz, Partner, leads Torreya’s Generic Pharmaceuticals Advisory team.

Allen has more than 20 years of business development, finance, and operating experience in life sciences. Having served in senior positions at the leading generics companies worldwide, he has worked on some of the largest transactions in the sector, including Sandoz’s landmark $1.5 billion acquisition of Fougera and Teva’s $3.4 billion acquisition of Sicor.

Before joining Torreya in 2013, Allen was Vice President of Business Development and Licensing at Sandoz USA, where he directed all generic and brand product licensing, as well as product and company acquisition activities. Previously, he spent nearly two decades at Teva in Israel and in the US, where he held positions in corporate and generics. He also served as global CFO of commercial operations for Teva API. He began his career at Schering-Plough.

Allen received his B.S. in economics and an M.B.A in finance/international business from New York University’s Stern School of Business. He is fluent in Hebrew.